NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cantargia AB (publ) (ST: CANTA)

 
CANTA Technical Analysis
5
As on 9th Jun 2023 CANTA STOCK Price closed @ 4.43 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 10.84 & Strong Sell for SHORT-TERM with Stoploss of 17.41 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CANTASTOCK Price

Open 4.64 Change Price %
High 4.64 1 Day -0.21 -4.53
Low 4.43 1 Week -0.24 -5.14
Close 4.43 1 Month -1.64 -27.02
Volume 778387 1 Year -13.85 -75.77
52 Week High 19.84 | 52 Week Low 3.01
 
ST Sweden Most Active Stocks
QUIA 0.02 0.00%
QLIFE 0.04 0.00%
SBB-B 5.38 3.07%
STRLNG 0.12 33.33%
LUNE 21.97 6.65%
SAS 0.36 5.88%
URBIT 0.02 0.00%
IDOGEN 0.15 -31.82%
STAR-B 0.89 -1.11%
TELIA 24.60 0.41%
 
ST Sweden Top Gainers Stocks
S2M 0.52 100.00%
NETM-B 1.35 42.11%
STRLNG 0.12 33.33%
IVACC 7.26 32.97%
SPRINT 0.63 16.67%
TH1NG 1.61 16.67%
ATIC 5.14 15.77%
ATIC 5.14 15.77%
CIRCHE 3.69 15.67%
AXIC-A 8.16 15.25%
 
ST Sweden Top Losers Stocks
IDOGEN 0.15 -31.82%
IMMU 0.72 -27.27%
ALLR 1.55 -26.54%
MIDW-A 24.80 -22.98%
KILI 0.76 -16.48%
FRACTL 36.80 -14.02%
DIVIO-B 0.13 -13.33%
ZZ-B 41.50 -12.08%
LIPI 1.49 -11.83%
BACTI-B 72.70 -10.69%
 
 
CANTA
Daily Charts
CANTA
Intraday Charts
Whats New @
Bazaartrend
CANTA
Free Analysis
 
CANTA Important Levels Intraday
RESISTANCE4.83
RESISTANCE4.70
RESISTANCE4.62
RESISTANCE4.54
SUPPORT4.32
SUPPORT4.24
SUPPORT4.16
SUPPORT4.03
 
CANTA Forecast April 2024
4th UP Forecast14.26
3rd UP Forecast11.11
2nd UP Forecast9.16
1st UP Forecast7.21
1st DOWN Forecast1.65
2nd DOWN Forecast-0.3
3rd DOWN Forecast-2.25
4th DOWN Forecast-5.4
 
CANTA Weekly Forecast
4th UP Forecast10.40
3rd UP Forecast8.49
2nd UP Forecast7.30
1st UP Forecast6.12
1st DOWN Forecast2.74
2nd DOWN Forecast1.56
3rd DOWN Forecast0.37
4th DOWN Forecast-1.54
 
CANTA Forecast2024
4th UP Forecast37.46
3rd UP Forecast26.87
2nd UP Forecast20.32
1st UP Forecast13.77
1st DOWN Forecast-4.91
2nd DOWN Forecast-11.46
3rd DOWN Forecast-18.01
4th DOWN Forecast-28.6
 
 
CANTA Other Details
Segment EQ
Market Capital 1699273216.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CANTA Address
CANTA
 
CANTA Latest News
 
Your Comments and Response on Cantargia AB (publ)
 
CANTA Business Profile
Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase1 clinical trial; and CAN10, an antibody against IL1RAP for treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis, and is under preclinical trial. It is also developing CANxx antibodies against IL1RAP that have other properties than CAN04 and CAN10. The company has collaboration agreements with Patheon Biologics BV and BioWa Inc. for the manufacture and production of CAN04; and Specialized Medical Services-oncology BV for the clinical study of CAN04. Cantargia AB (publ) was founded in 2010 and is based in Lund, Sweden. Address: ScheelevAegen 2, Lund, Sweden, 223 63
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service